Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kirschner

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|February 14, 2018
An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesotheliomaA Linton, Y Y Cheng, K Griggs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
ZIC1 is silenced and has tumor suppressor function in malignant pleural mesotheliomaYuen Yee Cheng, Michaela B Kirschner, Ngan Ching Cheng, et al.
Molecular Cancer Research : MCR|April 1, 2015
Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural MesotheliomaKimberly A Birnie, Yan Y Yip, Dominic C H Ng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural MesotheliomaSteven C Kao, Yuen Yee Cheng, Marissa Williams, et al.
Molecular Cancer|June 2, 2016
KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaYuen Yee Cheng, Casey M Wright, Michaela B Kirschner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2013
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesotheliomaG Reid, M E Pel, M B Kirschner, et al.
British Journal of Cancer|February 19, 2016
A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesotheliomaSteven C Kao, Michaela B Kirschner, Wendy A Cooper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2017
Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural MesotheliomaThomas G Johnson, Karin Schelch, Yuen Y Cheng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesotheliomaMichaela B Kirschner, Yuen Yee Cheng, Bahareh Badrian, et al.
Journal of Translational Medicine|October 21, 2016
Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, NorwayAna I Robles, Karina Standahl Olsen, Dana W T Tsui, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|February 14, 2018
An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesotheliomaA Linton, Y Y Cheng, K Griggs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2014
ZIC1 is silenced and has tumor suppressor function in malignant pleural mesotheliomaYuen Yee Cheng, Michaela B Kirschner, Ngan Ching Cheng, et al.
Molecular Cancer Research : MCR|April 1, 2015
Loss of miR-223 and JNK Signaling Contribute to Elevated Stathmin in Malignant Pleural MesotheliomaKimberly A Birnie, Yan Y Yip, Dominic C H Ng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 21, 2017
Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural MesotheliomaSteven C Kao, Yuen Yee Cheng, Marissa Williams, et al.
Molecular Cancer|June 2, 2016
KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesotheliomaYuen Yee Cheng, Casey M Wright, Michaela B Kirschner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2013
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesotheliomaG Reid, M E Pel, M B Kirschner, et al.
British Journal of Cancer|February 19, 2016
A proteomics-based approach identifies secreted protein acidic and rich in cysteine as a prognostic biomarker in malignant pleural mesotheliomaSteven C Kao, Michaela B Kirschner, Wendy A Cooper, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2017
Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural MesotheliomaThomas G Johnson, Karin Schelch, Yuen Y Cheng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 24, 2012
Increased circulating miR-625-3p: a potential biomarker for patients with malignant pleural mesotheliomaMichaela B Kirschner, Yuen Yee Cheng, Bahareh Badrian, et al.
Journal of Translational Medicine|October 21, 2016
Excerpts from the 1st international NTNU symposium on current and future clinical biomarkers of cancer: innovation and implementation, June 16th and 17th 2016, Trondheim, NorwayAna I Robles, Karina Standahl Olsen, Dana W T Tsui, et al.
Pageof 10